查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1589338

椎間盤退化性疾病市場：按產品類型、治療方法、最終用戶分類 - 全球預測 2025-2030

Degenerative Disc Disease Market by Product Type (Devices, Drugs), Treatment (Artificial Disc Replacement, Cervical Spine, Lumbar Spine), End-Users - Global Forecast 2025-2030
出版日期: | 出版商: 360iResearch | 英文 185 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

2023年椎間盤退化性疾病市場估值為20.2億美元，預計2024年將達到21.7億美元，複合年成長率為7.73%，到2030年將達到34.1億美元。

退化性疾病(DDD) 包括因椎間盤斷裂而導致的病症，通常由老齡化引起，但也由損傷和遺傳因素引起。這種疾病會導致嚴重的疼痛和行動問題。由於世界人口老化、久坐的生活方式和肥胖率上升，DDD 的發病率不斷增加，醫療產業正在加大研發投資，以創新治療方法和手術干預措施。應用範圍延伸至整形外科診所、醫院及專科復健中心，最終用戶為中重度DDD患者。市場開拓洞察表明，微創手術技術的持續發展，以及生技藥品注射和再生醫學等非手術干預措施，是關鍵的成長要素。用於診斷成像和客製化治療計劃的人工智慧的進步也推動了顯著的成長。

主要市場統計
基準年[2023] 20.2億美元
預測年份 [2024] 21.7億美元
預測年份 [2030] 34.1億美元
複合年成長率（%） 7.73%

再生醫學研究，特別是幹細胞療法和軟骨再生，是一個新興的商機，因為它有望成為一種非侵入性替代醫學。然而，高昂的治療成本、核准新治療方法的監管障礙以及低度開發地區缺乏早期疾病管理意識給市場成長帶來了挑戰。此外，儘管技術取得了進步，但新興市場對此類先進治療方法的採用仍然有限。利用這些機會的研究包括專注於成本削減策略、加強研究機構和醫療技術公司之間的合作以及加速創新。投資教育活動以提高人們對 DDD 早期檢測和管理的認知，可以建立一個巨大的開拓市場。該市場競爭激烈，但前景廣闊，在以患者為中心的治療和先進生技藥品方面具有巨大的創新空間。相關人員將個人化醫療、用於脊椎健康監測的穿戴式技術和用於患者資料分析的深度學習演算法方面的突破視為未來的重要開拓領域，以支持持續的市場擴張和患者成長，希望確保改善結果。

市場動態：揭示快速發展的退化性疾病市場的關鍵市場洞察

供需的動態交互作用正在改變退化性疾病市場。了解這些不斷變化的市場動態可以幫助企業做出明智的投資決策、策略決策並抓住新的商機。全面了解這些趨勢可以幫助企業降低政治、地理、技術、社會和經濟領域的風險，同時也能幫助消費行為及其對製造業的影響。

  • 市場促進因素
    • 退化性疾病增加
    • 對非手術治療方案的偏好日益增加
    • 物理治療和止痛藥物等保守治療的可用性
  • 市場限制因素
    • 手術費用上升
  • 市場機會
    • 退化性疾病治療的技術進展
    • 機器人技術在手術中的應用
  • 市場問題
    • 替代治療的可用性

波特的五力：駕馭退化性疾病市場的策略工具

波特的五力框架是了解市場競爭格局的重要工具。波特的五力框架描述了評估公司競爭和探索策略機會的清晰方法。該框架可幫助公司評估市場動態並確定新業務的盈利。這些見解使公司能夠利用自己的優勢，解決弱點並避免潛在的挑戰，從而確保更強大的市場地位。

PESTLE分析：了解退化性疾病市場的外部影響

外部宏觀環境因素在塑造椎間盤退化性疾病市場的表現動態發揮著至關重要的作用。對政治、經濟、社會、技術、法律和環境因素的分析提供了應對這些影響所需的資訊。透過調查 PESTLE 因素，公司可以更了解潛在的風險和機會。這種分析可以幫助企業預測法規、消費者偏好和經濟趨勢的變化，並為他們做出積極主動的決策做好準備。

市場佔有率分析：了解退化性疾病市場的競爭格局

椎間盤退化性疾病市場的詳細市場佔有率分析可以對供應商的表現進行全面評估。公司可以透過比較收益、客戶群和成長率等關鍵指標來揭示其競爭地位。該分析揭示了市場集中、細分和整合的趨勢，為供應商提供了製定策略決策所需的見解，以應對日益激烈的競爭。

FPNV 定位矩陣：椎間盤退化性疾病市場供應商績效評估

FPNV 定位矩陣是評估退化性疾病市場供應商的關鍵工具。此矩陣允許業務組織根據商務策略和產品滿意度評估供應商，從而做出與其目標相符的明智決策。這四個象限使您能夠清晰、準確地分類供應商，並確定最能滿足您的策略目標的合作夥伴和解決方案。

策略分析與建議：繪製退化性疾病市場的成功之路

對於旨在加強其在全球市場的影響力的公司來說，對退化性疾病市場的策略分析至關重要。透過審查關鍵資源、能力和績效指標，公司可以識別成長機會並努力改進。這種方法使您能夠克服競爭環境中的挑戰，利用新的商機並取得長期成功。

該報告對涵蓋關鍵焦點細分市場的市場進行了全面分析。

1.市場滲透率：對當前市場環境的詳細審查，主要企業的廣泛資料，評估他們在市場中的影響力和整體影響力。

2. 市場開拓：辨識新興市場的成長機會，評估現有細分市場的擴張潛力，並提供未來成長的策略藍圖。

3. 市場多元化：分析近期產品發布、開拓地區、關鍵產業進展、塑造市場的策略投資。

4. 競爭評估與情報：徹底分析競爭格局，檢驗市場佔有率、業務策略、產品系列、認證、監理核准、專利趨勢、主要企業的技術進步等。

5. 產品開發與創新：重點在於有望推動未來市場成長的最尖端科技、研發活動和產品創新。

它也回答重要問題，幫助相關人員做出明智的決策。

1.目前的市場規模和未來的成長預測是多少？

2. 哪些產品和地區提供最佳投資機會？

3.塑造市場的關鍵技術趨勢和監管影響是什麼？

4.主要廠商的市場佔有率和競爭地位如何？

5. 推動供應商市場進入和退出策略的收益來源和策略機會是什麼？

目錄

第1章 前言

第2章調查方法

第3章執行摘要

第4章市場概況

第5章市場洞察

  • 市場動態
    • 促進因素
      • 退化性椎間盤疾病的發生率增加
      • 非手術治療選擇越來越受歡迎
      • 物理治療和止痛藥物等保守治療的可用性
    • 抑制因素
      • 退化性疾病手術費用高
    • 機會
      • 退化性疾病治療的技術進展
      • 機器人技術在手術中的應用
    • 任務
      • 替代治療的可用性
  • 市場區隔分析
  • 波特五力分析
  • PESTEL分析
    • 政治
    • 經濟
    • 社會
    • 科技
    • 法律
    • 環境

第6章椎間盤退化性疾病市場：依產品類型

  • 介紹
  • 裝置
    • 頸椎
    • 腰椎
    • 脊椎融合手術
    • 胸椎
  • 藥品
    • 乙醯胺酚
    • 肌肉鬆弛劑
    • NSAID
    • 口服類固醇

第7章椎間盤退化性疾病市場：依治療分類

  • 介紹
  • 人工全人工椎間盤置換術
  • 頸椎
  • 腰椎
  • 脊椎融合手術
  • 胸椎

第8章椎間盤退化性疾病市場：依最終用戶分類

  • 介紹
  • 診所
  • 醫院

第9章美洲退化性疾病市場

  • 介紹
  • 阿根廷
  • 巴西
  • 加拿大
  • 墨西哥
  • 美國

第10章亞太退化性疾病市場

  • 介紹
  • 澳洲
  • 中國
  • 印度
  • 印尼
  • 日本
  • 馬來西亞
  • 菲律賓
  • 新加坡
  • 韓國
  • 台灣
  • 泰國
  • 越南

第11章歐洲/中東/非洲退化性疾病市場

  • 介紹
  • 丹麥
  • 埃及
  • 芬蘭
  • 法國
  • 德國
  • 以色列
  • 義大利
  • 荷蘭
  • 奈及利亞
  • 挪威
  • 波蘭
  • 卡達
  • 俄羅斯
  • 沙烏地阿拉伯
  • 南非
  • 西班牙
  • 瑞典
  • 瑞士
  • 土耳其
  • 阿拉伯聯合大公國
  • 英國

第12章競爭格局

  • 2023 年市場佔有率分析
  • FPNV 定位矩陣，2023
  • 競爭情境分析
  • 戰略分析和建議

公司名單

  • AnGes MG, Inc.
  • B. Braun SE
  • Biopharm GmbH
  • Cerapedics Inc.
  • DePuy Synthes by Medical Device Business Services, Inc.
  • Globus Medical Inc.
  • Kolon TissueGene Inc.
  • Lineage Cell Therapeutics, Inc.
  • Medtronic PLC
  • NLC Ventures Netherlands BV
  • Notogen, Inc.
  • Pfizer Inc.
  • Smith & Nephew PLC
  • Ulrich Medical USA Inc.
  • Zimmer Biomet Holdings Inc.
Product Code: MRR-4659C8712D83

The Degenerative Disc Disease Market was valued at USD 2.02 billion in 2023, expected to reach USD 2.17 billion in 2024, and is projected to grow at a CAGR of 7.73%, to USD 3.41 billion by 2030.

Degenerative Disc Disease (DDD) encompasses a condition that arises from the wear-and-tear of intervertebral discs, commonly attributing to aging but also facilitated by injury and genetic factors. This condition can lead to severe pain and mobility issues. Necessitated by the growing incidence of DDD, driven by an aging global population, sedentary lifestyles, and rising obesity rates, the healthcare industry is increasingly investing in research and development to innovate therapeutic and surgical interventions. The application scope extends to orthopedic clinics, hospitals, and specialized rehabilitation centers with end-users being patients suffering from moderate to severe forms of DDD. Market insights reveal that continuous developments in minimally invasive surgical techniques, along with non-surgical interventions like biologic injections and regenerative medicines, are critical growth influencers. Advances in artificial intelligence for diagnostic imaging and tailored treatment plans also provide significant growth traction.

KEY MARKET STATISTICS
Base Year [2023] USD 2.02 billion
Estimated Year [2024] USD 2.17 billion
Forecast Year [2030] USD 3.41 billion
CAGR (%) 7.73%

Opportunities emerge in regenerative medicine research, particularly stem cell therapy and cartilage regeneration, as they present promising non-invasive alternatives. However, market growth is challenged by high treatment costs, regulatory hurdles in approving new treatments, and a lack of awareness about early-stage disease management in underdeveloped regions. Moreover, despite technological advancements, the penetration of such sophisticated treatments in emerging markets remains limited. Recommendations for capitalizing on these opportunities include focusing on cost reduction strategies and increasing collaboration between research institutions and medical technology firms to fast-track innovation. Investment in educational initiatives to raise awareness about early detection and management of DDD can establish large untapped markets. The nature of the market is highly competitive yet promising, with substantial room for innovation in patient-centric therapies and advanced biologics. Stakeholders are encouraged to prioritize breakthroughs in personalized medicine, wearable technology for spinal health monitoring, and deep learning algorithms for patient data analysis as pivotal areas for future developments, ensuring sustained market expansion and improved patient outcomes.

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving Degenerative Disc Disease Market

The Degenerative Disc Disease Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

  • Market Drivers
    • Rising occurrences of degenerative disc disorders
    • Increasing preference for non-surgical treatment options
    • Availability of conservative therapies such as physical therapy, and pain relievers
  • Market Restraints
    • High cost of degenerative disc disease surgeries
  • Market Opportunities
    • Technological advancements in degenerative disc disease treatments
    • Introduction of robotic technology in surgical procedures
  • Market Challenges
    • Availability of alternative therapies

Porter's Five Forces: A Strategic Tool for Navigating the Degenerative Disc Disease Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the Degenerative Disc Disease Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the Degenerative Disc Disease Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the Degenerative Disc Disease Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the Degenerative Disc Disease Market

A detailed market share analysis in the Degenerative Disc Disease Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the Degenerative Disc Disease Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the Degenerative Disc Disease Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Strategy Analysis & Recommendation: Charting a Path to Success in the Degenerative Disc Disease Market

A strategic analysis of the Degenerative Disc Disease Market is essential for businesses looking to strengthen their global market presence. By reviewing key resources, capabilities, and performance indicators, business organizations can identify growth opportunities and work toward improvement. This approach helps businesses navigate challenges in the competitive landscape and ensures they are well-positioned to capitalize on newer opportunities and drive long-term success.

Key Company Profiles

The report delves into recent significant developments in the Degenerative Disc Disease Market, highlighting leading vendors and their innovative profiles. These include AnGes MG, Inc., B. Braun SE, Biopharm GmbH, Cerapedics Inc., DePuy Synthes by Medical Device Business Services, Inc., Globus Medical Inc., Kolon TissueGene Inc., Lineage Cell Therapeutics, Inc., Medtronic PLC, NLC Ventures Netherlands B.V., Notogen, Inc., Pfizer Inc., Smith & Nephew PLC, Ulrich Medical USA Inc., and Zimmer Biomet Holdings Inc..

Market Segmentation & Coverage

This research report categorizes the Degenerative Disc Disease Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Based on Product Type, market is studied across Devices and Drugs. The Devices is further studied across Cervical Spine, Lumbar Spine, Spinal Fusion, and Thoracic Spine. The Drugs is further studied across Acetaminophen, Muscle Relaxants, NSAIDs, and Oral Steroids.
  • Based on Treatment, market is studied across Artificial Disc Replacement, Cervical Spine, Lumbar Spine, Spinal Fusion, and Thoracic Spine.
  • Based on End-Users, market is studied across Clinics and Hospitals.
  • Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Rising occurrences of degenerative disc disorders
      • 5.1.1.2. Increasing preference for non-surgical treatment options
      • 5.1.1.3. Availability of conservative therapies such as physical therapy, and pain relievers
    • 5.1.2. Restraints
      • 5.1.2.1. High cost of degenerative disc disease surgeries
    • 5.1.3. Opportunities
      • 5.1.3.1. Technological advancements in degenerative disc disease treatments
      • 5.1.3.2. Introduction of robotic technology in surgical procedures
    • 5.1.4. Challenges
      • 5.1.4.1. Availability of alternative therapies
  • 5.2. Market Segmentation Analysis
  • 5.3. Porter's Five Forces Analysis
    • 5.3.1. Threat of New Entrants
    • 5.3.2. Threat of Substitutes
    • 5.3.3. Bargaining Power of Customers
    • 5.3.4. Bargaining Power of Suppliers
    • 5.3.5. Industry Rivalry
  • 5.4. PESTLE Analysis
    • 5.4.1. Political
    • 5.4.2. Economic
    • 5.4.3. Social
    • 5.4.4. Technological
    • 5.4.5. Legal
    • 5.4.6. Environmental

6. Degenerative Disc Disease Market, by Product Type

  • 6.1. Introduction
  • 6.2. Devices
    • 6.2.1. Cervical Spine
    • 6.2.2. Lumbar Spine
    • 6.2.3. Spinal Fusion
    • 6.2.4. Thoracic Spine
  • 6.3. Drugs
    • 6.3.1. Acetaminophen
    • 6.3.2. Muscle Relaxants
    • 6.3.3. NSAIDs
    • 6.3.4. Oral Steroids

7. Degenerative Disc Disease Market, by Treatment

  • 7.1. Introduction
  • 7.2. Artificial Disc Replacement
  • 7.3. Cervical Spine
  • 7.4. Lumbar Spine
  • 7.5. Spinal Fusion
  • 7.6. Thoracic Spine

8. Degenerative Disc Disease Market, by End-Users

  • 8.1. Introduction
  • 8.2. Clinics
  • 8.3. Hospitals

9. Americas Degenerative Disc Disease Market

  • 9.1. Introduction
  • 9.2. Argentina
  • 9.3. Brazil
  • 9.4. Canada
  • 9.5. Mexico
  • 9.6. United States

10. Asia-Pacific Degenerative Disc Disease Market

  • 10.1. Introduction
  • 10.2. Australia
  • 10.3. China
  • 10.4. India
  • 10.5. Indonesia
  • 10.6. Japan
  • 10.7. Malaysia
  • 10.8. Philippines
  • 10.9. Singapore
  • 10.10. South Korea
  • 10.11. Taiwan
  • 10.12. Thailand
  • 10.13. Vietnam

11. Europe, Middle East & Africa Degenerative Disc Disease Market

  • 11.1. Introduction
  • 11.2. Denmark
  • 11.3. Egypt
  • 11.4. Finland
  • 11.5. France
  • 11.6. Germany
  • 11.7. Israel
  • 11.8. Italy
  • 11.9. Netherlands
  • 11.10. Nigeria
  • 11.11. Norway
  • 11.12. Poland
  • 11.13. Qatar
  • 11.14. Russia
  • 11.15. Saudi Arabia
  • 11.16. South Africa
  • 11.17. Spain
  • 11.18. Sweden
  • 11.19. Switzerland
  • 11.20. Turkey
  • 11.21. United Arab Emirates
  • 11.22. United Kingdom

12. Competitive Landscape

  • 12.1. Market Share Analysis, 2023
  • 12.2. FPNV Positioning Matrix, 2023
  • 12.3. Competitive Scenario Analysis
  • 12.4. Strategy Analysis & Recommendation

Companies Mentioned

  • 1. AnGes MG, Inc.
  • 2. B. Braun SE
  • 3. Biopharm GmbH
  • 4. Cerapedics Inc.
  • 5. DePuy Synthes by Medical Device Business Services, Inc.
  • 6. Globus Medical Inc.
  • 7. Kolon TissueGene Inc.
  • 8. Lineage Cell Therapeutics, Inc.
  • 9. Medtronic PLC
  • 10. NLC Ventures Netherlands B.V.
  • 11. Notogen, Inc.
  • 12. Pfizer Inc.
  • 13. Smith & Nephew PLC
  • 14. Ulrich Medical USA Inc.
  • 15. Zimmer Biomet Holdings Inc.

LIST OF FIGURES

  • FIGURE 1. DEGENERATIVE DISC DISEASE MARKET RESEARCH PROCESS
  • FIGURE 2. DEGENERATIVE DISC DISEASE MARKET SIZE, 2023 VS 2030
  • FIGURE 3. GLOBAL DEGENERATIVE DISC DISEASE MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 4. GLOBAL DEGENERATIVE DISC DISEASE MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 5. GLOBAL DEGENERATIVE DISC DISEASE MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 6. GLOBAL DEGENERATIVE DISC DISEASE MARKET SIZE, BY PRODUCT TYPE, 2023 VS 2030 (%)
  • FIGURE 7. GLOBAL DEGENERATIVE DISC DISEASE MARKET SIZE, BY PRODUCT TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 8. GLOBAL DEGENERATIVE DISC DISEASE MARKET SIZE, BY TREATMENT, 2023 VS 2030 (%)
  • FIGURE 9. GLOBAL DEGENERATIVE DISC DISEASE MARKET SIZE, BY TREATMENT, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 10. GLOBAL DEGENERATIVE DISC DISEASE MARKET SIZE, BY END-USERS, 2023 VS 2030 (%)
  • FIGURE 11. GLOBAL DEGENERATIVE DISC DISEASE MARKET SIZE, BY END-USERS, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 12. AMERICAS DEGENERATIVE DISC DISEASE MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 13. AMERICAS DEGENERATIVE DISC DISEASE MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 14. UNITED STATES DEGENERATIVE DISC DISEASE MARKET SIZE, BY STATE, 2023 VS 2030 (%)
  • FIGURE 15. UNITED STATES DEGENERATIVE DISC DISEASE MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 16. ASIA-PACIFIC DEGENERATIVE DISC DISEASE MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 17. ASIA-PACIFIC DEGENERATIVE DISC DISEASE MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 18. EUROPE, MIDDLE EAST & AFRICA DEGENERATIVE DISC DISEASE MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 19. EUROPE, MIDDLE EAST & AFRICA DEGENERATIVE DISC DISEASE MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 20. DEGENERATIVE DISC DISEASE MARKET SHARE, BY KEY PLAYER, 2023
  • FIGURE 21. DEGENERATIVE DISC DISEASE MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

  • TABLE 1. DEGENERATIVE DISC DISEASE MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
  • TABLE 3. GLOBAL DEGENERATIVE DISC DISEASE MARKET SIZE, 2018-2030 (USD MILLION)
  • TABLE 4. GLOBAL DEGENERATIVE DISC DISEASE MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 5. GLOBAL DEGENERATIVE DISC DISEASE MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 6. DEGENERATIVE DISC DISEASE MARKET DYNAMICS
  • TABLE 7. GLOBAL DEGENERATIVE DISC DISEASE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 8. GLOBAL DEGENERATIVE DISC DISEASE MARKET SIZE, BY DEVICES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 9. GLOBAL DEGENERATIVE DISC DISEASE MARKET SIZE, BY CERVICAL SPINE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 10. GLOBAL DEGENERATIVE DISC DISEASE MARKET SIZE, BY LUMBAR SPINE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 11. GLOBAL DEGENERATIVE DISC DISEASE MARKET SIZE, BY SPINAL FUSION, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 12. GLOBAL DEGENERATIVE DISC DISEASE MARKET SIZE, BY THORACIC SPINE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 13. GLOBAL DEGENERATIVE DISC DISEASE MARKET SIZE, BY DEVICES, 2018-2030 (USD MILLION)
  • TABLE 14. GLOBAL DEGENERATIVE DISC DISEASE MARKET SIZE, BY DRUGS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 15. GLOBAL DEGENERATIVE DISC DISEASE MARKET SIZE, BY ACETAMINOPHEN, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 16. GLOBAL DEGENERATIVE DISC DISEASE MARKET SIZE, BY MUSCLE RELAXANTS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 17. GLOBAL DEGENERATIVE DISC DISEASE MARKET SIZE, BY NSAIDS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 18. GLOBAL DEGENERATIVE DISC DISEASE MARKET SIZE, BY ORAL STEROIDS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 19. GLOBAL DEGENERATIVE DISC DISEASE MARKET SIZE, BY DRUGS, 2018-2030 (USD MILLION)
  • TABLE 20. GLOBAL DEGENERATIVE DISC DISEASE MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 21. GLOBAL DEGENERATIVE DISC DISEASE MARKET SIZE, BY ARTIFICIAL DISC REPLACEMENT, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 22. GLOBAL DEGENERATIVE DISC DISEASE MARKET SIZE, BY CERVICAL SPINE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 23. GLOBAL DEGENERATIVE DISC DISEASE MARKET SIZE, BY LUMBAR SPINE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 24. GLOBAL DEGENERATIVE DISC DISEASE MARKET SIZE, BY SPINAL FUSION, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 25. GLOBAL DEGENERATIVE DISC DISEASE MARKET SIZE, BY THORACIC SPINE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 26. GLOBAL DEGENERATIVE DISC DISEASE MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
  • TABLE 27. GLOBAL DEGENERATIVE DISC DISEASE MARKET SIZE, BY CLINICS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 28. GLOBAL DEGENERATIVE DISC DISEASE MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 29. AMERICAS DEGENERATIVE DISC DISEASE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 30. AMERICAS DEGENERATIVE DISC DISEASE MARKET SIZE, BY DEVICES, 2018-2030 (USD MILLION)
  • TABLE 31. AMERICAS DEGENERATIVE DISC DISEASE MARKET SIZE, BY DRUGS, 2018-2030 (USD MILLION)
  • TABLE 32. AMERICAS DEGENERATIVE DISC DISEASE MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 33. AMERICAS DEGENERATIVE DISC DISEASE MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
  • TABLE 34. AMERICAS DEGENERATIVE DISC DISEASE MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 35. ARGENTINA DEGENERATIVE DISC DISEASE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 36. ARGENTINA DEGENERATIVE DISC DISEASE MARKET SIZE, BY DEVICES, 2018-2030 (USD MILLION)
  • TABLE 37. ARGENTINA DEGENERATIVE DISC DISEASE MARKET SIZE, BY DRUGS, 2018-2030 (USD MILLION)
  • TABLE 38. ARGENTINA DEGENERATIVE DISC DISEASE MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 39. ARGENTINA DEGENERATIVE DISC DISEASE MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
  • TABLE 40. BRAZIL DEGENERATIVE DISC DISEASE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 41. BRAZIL DEGENERATIVE DISC DISEASE MARKET SIZE, BY DEVICES, 2018-2030 (USD MILLION)
  • TABLE 42. BRAZIL DEGENERATIVE DISC DISEASE MARKET SIZE, BY DRUGS, 2018-2030 (USD MILLION)
  • TABLE 43. BRAZIL DEGENERATIVE DISC DISEASE MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 44. BRAZIL DEGENERATIVE DISC DISEASE MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
  • TABLE 45. CANADA DEGENERATIVE DISC DISEASE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 46. CANADA DEGENERATIVE DISC DISEASE MARKET SIZE, BY DEVICES, 2018-2030 (USD MILLION)
  • TABLE 47. CANADA DEGENERATIVE DISC DISEASE MARKET SIZE, BY DRUGS, 2018-2030 (USD MILLION)
  • TABLE 48. CANADA DEGENERATIVE DISC DISEASE MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 49. CANADA DEGENERATIVE DISC DISEASE MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
  • TABLE 50. MEXICO DEGENERATIVE DISC DISEASE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 51. MEXICO DEGENERATIVE DISC DISEASE MARKET SIZE, BY DEVICES, 2018-2030 (USD MILLION)
  • TABLE 52. MEXICO DEGENERATIVE DISC DISEASE MARKET SIZE, BY DRUGS, 2018-2030 (USD MILLION)
  • TABLE 53. MEXICO DEGENERATIVE DISC DISEASE MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 54. MEXICO DEGENERATIVE DISC DISEASE MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
  • TABLE 55. UNITED STATES DEGENERATIVE DISC DISEASE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 56. UNITED STATES DEGENERATIVE DISC DISEASE MARKET SIZE, BY DEVICES, 2018-2030 (USD MILLION)
  • TABLE 57. UNITED STATES DEGENERATIVE DISC DISEASE MARKET SIZE, BY DRUGS, 2018-2030 (USD MILLION)
  • TABLE 58. UNITED STATES DEGENERATIVE DISC DISEASE MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 59. UNITED STATES DEGENERATIVE DISC DISEASE MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
  • TABLE 60. UNITED STATES DEGENERATIVE DISC DISEASE MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
  • TABLE 61. ASIA-PACIFIC DEGENERATIVE DISC DISEASE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 62. ASIA-PACIFIC DEGENERATIVE DISC DISEASE MARKET SIZE, BY DEVICES, 2018-2030 (USD MILLION)
  • TABLE 63. ASIA-PACIFIC DEGENERATIVE DISC DISEASE MARKET SIZE, BY DRUGS, 2018-2030 (USD MILLION)
  • TABLE 64. ASIA-PACIFIC DEGENERATIVE DISC DISEASE MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 65. ASIA-PACIFIC DEGENERATIVE DISC DISEASE MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
  • TABLE 66. ASIA-PACIFIC DEGENERATIVE DISC DISEASE MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 67. AUSTRALIA DEGENERATIVE DISC DISEASE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 68. AUSTRALIA DEGENERATIVE DISC DISEASE MARKET SIZE, BY DEVICES, 2018-2030 (USD MILLION)
  • TABLE 69. AUSTRALIA DEGENERATIVE DISC DISEASE MARKET SIZE, BY DRUGS, 2018-2030 (USD MILLION)
  • TABLE 70. AUSTRALIA DEGENERATIVE DISC DISEASE MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 71. AUSTRALIA DEGENERATIVE DISC DISEASE MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
  • TABLE 72. CHINA DEGENERATIVE DISC DISEASE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 73. CHINA DEGENERATIVE DISC DISEASE MARKET SIZE, BY DEVICES, 2018-2030 (USD MILLION)
  • TABLE 74. CHINA DEGENERATIVE DISC DISEASE MARKET SIZE, BY DRUGS, 2018-2030 (USD MILLION)
  • TABLE 75. CHINA DEGENERATIVE DISC DISEASE MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 76. CHINA DEGENERATIVE DISC DISEASE MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
  • TABLE 77. INDIA DEGENERATIVE DISC DISEASE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 78. INDIA DEGENERATIVE DISC DISEASE MARKET SIZE, BY DEVICES, 2018-2030 (USD MILLION)
  • TABLE 79. INDIA DEGENERATIVE DISC DISEASE MARKET SIZE, BY DRUGS, 2018-2030 (USD MILLION)
  • TABLE 80. INDIA DEGENERATIVE DISC DISEASE MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 81. INDIA DEGENERATIVE DISC DISEASE MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
  • TABLE 82. INDONESIA DEGENERATIVE DISC DISEASE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 83. INDONESIA DEGENERATIVE DISC DISEASE MARKET SIZE, BY DEVICES, 2018-2030 (USD MILLION)
  • TABLE 84. INDONESIA DEGENERATIVE DISC DISEASE MARKET SIZE, BY DRUGS, 2018-2030 (USD MILLION)
  • TABLE 85. INDONESIA DEGENERATIVE DISC DISEASE MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 86. INDONESIA DEGENERATIVE DISC DISEASE MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
  • TABLE 87. JAPAN DEGENERATIVE DISC DISEASE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 88. JAPAN DEGENERATIVE DISC DISEASE MARKET SIZE, BY DEVICES, 2018-2030 (USD MILLION)
  • TABLE 89. JAPAN DEGENERATIVE DISC DISEASE MARKET SIZE, BY DRUGS, 2018-2030 (USD MILLION)
  • TABLE 90. JAPAN DEGENERATIVE DISC DISEASE MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 91. JAPAN DEGENERATIVE DISC DISEASE MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
  • TABLE 92. MALAYSIA DEGENERATIVE DISC DISEASE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 93. MALAYSIA DEGENERATIVE DISC DISEASE MARKET SIZE, BY DEVICES, 2018-2030 (USD MILLION)
  • TABLE 94. MALAYSIA DEGENERATIVE DISC DISEASE MARKET SIZE, BY DRUGS, 2018-2030 (USD MILLION)
  • TABLE 95. MALAYSIA DEGENERATIVE DISC DISEASE MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 96. MALAYSIA DEGENERATIVE DISC DISEASE MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
  • TABLE 97. PHILIPPINES DEGENERATIVE DISC DISEASE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 98. PHILIPPINES DEGENERATIVE DISC DISEASE MARKET SIZE, BY DEVICES, 2018-2030 (USD MILLION)
  • TABLE 99. PHILIPPINES DEGENERATIVE DISC DISEASE MARKET SIZE, BY DRUGS, 2018-2030 (USD MILLION)
  • TABLE 100. PHILIPPINES DEGENERATIVE DISC DISEASE MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 101. PHILIPPINES DEGENERATIVE DISC DISEASE MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
  • TABLE 102. SINGAPORE DEGENERATIVE DISC DISEASE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 103. SINGAPORE DEGENERATIVE DISC DISEASE MARKET SIZE, BY DEVICES, 2018-2030 (USD MILLION)
  • TABLE 104. SINGAPORE DEGENERATIVE DISC DISEASE MARKET SIZE, BY DRUGS, 2018-2030 (USD MILLION)
  • TABLE 105. SINGAPORE DEGENERATIVE DISC DISEASE MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 106. SINGAPORE DEGENERATIVE DISC DISEASE MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
  • TABLE 107. SOUTH KOREA DEGENERATIVE DISC DISEASE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 108. SOUTH KOREA DEGENERATIVE DISC DISEASE MARKET SIZE, BY DEVICES, 2018-2030 (USD MILLION)
  • TABLE 109. SOUTH KOREA DEGENERATIVE DISC DISEASE MARKET SIZE, BY DRUGS, 2018-2030 (USD MILLION)
  • TABLE 110. SOUTH KOREA DEGENERATIVE DISC DISEASE MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 111. SOUTH KOREA DEGENERATIVE DISC DISEASE MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
  • TABLE 112. TAIWAN DEGENERATIVE DISC DISEASE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 113. TAIWAN DEGENERATIVE DISC DISEASE MARKET SIZE, BY DEVICES, 2018-2030 (USD MILLION)
  • TABLE 114. TAIWAN DEGENERATIVE DISC DISEASE MARKET SIZE, BY DRUGS, 2018-2030 (USD MILLION)
  • TABLE 115. TAIWAN DEGENERATIVE DISC DISEASE MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 116. TAIWAN DEGENERATIVE DISC DISEASE MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
  • TABLE 117. THAILAND DEGENERATIVE DISC DISEASE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 118. THAILAND DEGENERATIVE DISC DISEASE MARKET SIZE, BY DEVICES, 2018-2030 (USD MILLION)
  • TABLE 119. THAILAND DEGENERATIVE DISC DISEASE MARKET SIZE, BY DRUGS, 2018-2030 (USD MILLION)
  • TABLE 120. THAILAND DEGENERATIVE DISC DISEASE MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 121. THAILAND DEGENERATIVE DISC DISEASE MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
  • TABLE 122. VIETNAM DEGENERATIVE DISC DISEASE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 123. VIETNAM DEGENERATIVE DISC DISEASE MARKET SIZE, BY DEVICES, 2018-2030 (USD MILLION)
  • TABLE 124. VIETNAM DEGENERATIVE DISC DISEASE MARKET SIZE, BY DRUGS, 2018-2030 (USD MILLION)
  • TABLE 125. VIETNAM DEGENERATIVE DISC DISEASE MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 126. VIETNAM DEGENERATIVE DISC DISEASE MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
  • TABLE 127. EUROPE, MIDDLE EAST & AFRICA DEGENERATIVE DISC DISEASE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 128. EUROPE, MIDDLE EAST & AFRICA DEGENERATIVE DISC DISEASE MARKET SIZE, BY DEVICES, 2018-2030 (USD MILLION)
  • TABLE 129. EUROPE, MIDDLE EAST & AFRICA DEGENERATIVE DISC DISEASE MARKET SIZE, BY DRUGS, 2018-2030 (USD MILLION)
  • TABLE 130. EUROPE, MIDDLE EAST & AFRICA DEGENERATIVE DISC DISEASE MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 131. EUROPE, MIDDLE EAST & AFRICA DEGENERATIVE DISC DISEASE MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
  • TABLE 132. EUROPE, MIDDLE EAST & AFRICA DEGENERATIVE DISC DISEASE MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 133. DENMARK DEGENERATIVE DISC DISEASE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 134. DENMARK DEGENERATIVE DISC DISEASE MARKET SIZE, BY DEVICES, 2018-2030 (USD MILLION)
  • TABLE 135. DENMARK DEGENERATIVE DISC DISEASE MARKET SIZE, BY DRUGS, 2018-2030 (USD MILLION)
  • TABLE 136. DENMARK DEGENERATIVE DISC DISEASE MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 137. DENMARK DEGENERATIVE DISC DISEASE MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
  • TABLE 138. EGYPT DEGENERATIVE DISC DISEASE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 139. EGYPT DEGENERATIVE DISC DISEASE MARKET SIZE, BY DEVICES, 2018-2030 (USD MILLION)
  • TABLE 140. EGYPT DEGENERATIVE DISC DISEASE MARKET SIZE, BY DRUGS, 2018-2030 (USD MILLION)
  • TABLE 141. EGYPT DEGENERATIVE DISC DISEASE MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 142. EGYPT DEGENERATIVE DISC DISEASE MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
  • TABLE 143. FINLAND DEGENERATIVE DISC DISEASE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 144. FINLAND DEGENERATIVE DISC DISEASE MARKET SIZE, BY DEVICES, 2018-2030 (USD MILLION)
  • TABLE 145. FINLAND DEGENERATIVE DISC DISEASE MARKET SIZE, BY DRUGS, 2018-2030 (USD MILLION)
  • TABLE 146. FINLAND DEGENERATIVE DISC DISEASE MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 147. FINLAND DEGENERATIVE DISC DISEASE MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
  • TABLE 148. FRANCE DEGENERATIVE DISC DISEASE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 149. FRANCE DEGENERATIVE DISC DISEASE MARKET SIZE, BY DEVICES, 2018-2030 (USD MILLION)
  • TABLE 150. FRANCE DEGENERATIVE DISC DISEASE MARKET SIZE, BY DRUGS, 2018-2030 (USD MILLION)
  • TABLE 151. FRANCE DEGENERATIVE DISC DISEASE MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 152. FRANCE DEGENERATIVE DISC DISEASE MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
  • TABLE 153. GERMANY DEGENERATIVE DISC DISEASE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 154. GERMANY DEGENERATIVE DISC DISEASE MARKET SIZE, BY DEVICES, 2018-2030 (USD MILLION)
  • TABLE 155. GERMANY DEGENERATIVE DISC DISEASE MARKET SIZE, BY DRUGS, 2018-2030 (USD MILLION)
  • TABLE 156. GERMANY DEGENERATIVE DISC DISEASE MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 157. GERMANY DEGENERATIVE DISC DISEASE MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
  • TABLE 158. ISRAEL DEGENERATIVE DISC DISEASE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 159. ISRAEL DEGENERATIVE DISC DISEASE MARKET SIZE, BY DEVICES, 2018-2030 (USD MILLION)
  • TABLE 160. ISRAEL DEGENERATIVE DISC DISEASE MARKET SIZE, BY DRUGS, 2018-2030 (USD MILLION)
  • TABLE 161. ISRAEL DEGENERATIVE DISC DISEASE MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 162. ISRAEL DEGENERATIVE DISC DISEASE MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
  • TABLE 163. ITALY DEGENERATIVE DISC DISEASE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 164. ITALY DEGENERATIVE DISC DISEASE MARKET SIZE, BY DEVICES, 2018-2030 (USD MILLION)
  • TABLE 165. ITALY DEGENERATIVE DISC DISEASE MARKET SIZE, BY DRUGS, 2018-2030 (USD MILLION)
  • TABLE 166. ITALY DEGENERATIVE DISC DISEASE MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 167. ITALY DEGENERATIVE DISC DISEASE MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
  • TABLE 168. NETHERLANDS DEGENERATIVE DISC DISEASE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 169. NETHERLANDS DEGENERATIVE DISC DISEASE MARKET SIZE, BY DEVICES, 2018-2030 (USD MILLION)
  • TABLE 170. NETHERLANDS DEGENERATIVE DISC DISEASE MARKET SIZE, BY DRUGS, 2018-2030 (USD MILLION)
  • TABLE 171. NETHERLANDS DEGENERATIVE DISC DISEASE MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 172. NETHERLANDS DEGENERATIVE DISC DISEASE MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
  • TABLE 173. NIGERIA DEGENERATIVE DISC DISEASE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 174. NIGERIA DEGENERATIVE DISC DISEASE MARKET SIZE, BY DEVICES, 2018-2030 (USD MILLION)
  • TABLE 175. NIGERIA DEGENERATIVE DISC DISEASE MARKET SIZE, BY DRUGS, 2018-2030 (USD MILLION)
  • TABLE 176. NIGERIA DEGENERATIVE DISC DISEASE MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 177. NIGERIA DEGENERATIVE DISC DISEASE MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
  • TABLE 178. NORWAY DEGENERATIVE DISC DISEASE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 179. NORWAY DEGENERATIVE DISC DISEASE MARKET SIZE, BY DEVICES, 2018-2030 (USD MILLION)
  • TABLE 180. NORWAY DEGENERATIVE DISC DISEASE MARKET SIZE, BY DRUGS, 2018-2030 (USD MILLION)
  • TABLE 181. NORWAY DEGENERATIVE DISC DISEASE MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 182. NORWAY DEGENERATIVE DISC DISEASE MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
  • TABLE 183. POLAND DEGENERATIVE DISC DISEASE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 184. POLAND DEGENERATIVE DISC DISEASE MARKET SIZE, BY DEVICES, 2018-2030 (USD MILLION)
  • TABLE 185. POLAND DEGENERATIVE DISC DISEASE MARKET SIZE, BY DRUGS, 2018-2030 (USD MILLION)
  • TABLE 186. POLAND DEGENERATIVE DISC DISEASE MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 187. POLAND DEGENERATIVE DISC DISEASE MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
  • TABLE 188. QATAR DEGENERATIVE DISC DISEASE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 189. QATAR DEGENERATIVE DISC DISEASE MARKET SIZE, BY DEVICES, 2018-2030 (USD MILLION)
  • TABLE 190. QATAR DEGENERATIVE DISC DISEASE MARKET SIZE, BY DRUGS, 2018-2030 (USD MILLION)
  • TABLE 191. QATAR DEGENERATIVE DISC DISEASE MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 192. QATAR DEGENERATIVE DISC DISEASE MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
  • TABLE 193. RUSSIA DEGENERATIVE DISC DISEASE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 194. RUSSIA DEGENERATIVE DISC DISEASE MARKET SIZE, BY DEVICES, 2018-2030 (USD MILLION)
  • TABLE 195. RUSSIA DEGENERATIVE DISC DISEASE MARKET SIZE, BY DRUGS, 2018-2030 (USD MILLION)
  • TABLE 196. RUSSIA DEGENERATIVE DISC DISEASE MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 197. RUSSIA DEGENERATIVE DISC DISEASE MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
  • TABLE 198. SAUDI ARABIA DEGENERATIVE DISC DISEASE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 199. SAUDI ARABIA DEGENERATIVE DISC DISEASE MARKET SIZE, BY DEVICES, 2018-2030 (USD MILLION)
  • TABLE 200. SAUDI ARABIA DEGENERATIVE DISC DISEASE MARKET SIZE, BY DRUGS, 2018-2030 (USD MILLION)
  • TABLE 201. SAUDI ARABIA DEGENERATIVE DISC DISEASE MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 202. SAUDI ARABIA DEGENERATIVE DISC DISEASE MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
  • TABLE 203. SOUTH AFRICA DEGENERATIVE DISC DISEASE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 204. SOUTH AFRICA DEGENERATIVE DISC DISEASE MARKET SIZE, BY DEVICES, 2018-2030 (USD MILLION)
  • TABLE 205. SOUTH AFRICA DEGENERATIVE DISC DISEASE MARKET SIZE, BY DRUGS, 2018-2030 (USD MILLION)
  • TABLE 206. SOUTH AFRICA DEGENERATIVE DISC DISEASE MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 207. SOUTH AFRICA DEGENERATIVE DISC DISEASE MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
  • TABLE 208. SPAIN DEGENERATIVE DISC DISEASE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 209. SPAIN DEGENERATIVE DISC DISEASE MARKET SIZE, BY DEVICES, 2018-2030 (USD MILLION)
  • TABLE 210. SPAIN DEGENERATIVE DISC DISEASE MARKET SIZE, BY DRUGS, 2018-2030 (USD MILLION)
  • TABLE 211. SPAIN DEGENERATIVE DISC DISEASE MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 212. SPAIN DEGENERATIVE DISC DISEASE MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
  • TABLE 213. SWEDEN DEGENERATIVE DISC DISEASE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 214. SWEDEN DEGENERATIVE DISC DISEASE MARKET SIZE, BY DEVICES, 2018-2030 (USD MILLION)
  • TABLE 215. SWEDEN DEGENERATIVE DISC DISEASE MARKET SIZE, BY DRUGS, 2018-2030 (USD MILLION)
  • TABLE 216. SWEDEN DEGENERATIVE DISC DISEASE MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 217. SWEDEN DEGENERATIVE DISC DISEASE MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
  • TABLE 218. SWITZERLAND DEGENERATIVE DISC DISEASE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 219. SWITZERLAND DEGENERATIVE DISC DISEASE MARKET SIZE, BY DEVICES, 2018-2030 (USD MILLION)
  • TABLE 220. SWITZERLAND DEGENERATIVE DISC DISEASE MARKET SIZE, BY DRUGS, 2018-2030 (USD MILLION)
  • TABLE 221. SWITZERLAND DEGENERATIVE DISC DISEASE MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 222. SWITZERLAND DEGENERATIVE DISC DISEASE MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
  • TABLE 223. TURKEY DEGENERATIVE DISC DISEASE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 224. TURKEY DEGENERATIVE DISC DISEASE MARKET SIZE, BY DEVICES, 2018-2030 (USD MILLION)
  • TABLE 225. TURKEY DEGENERATIVE DISC DISEASE MARKET SIZE, BY DRUGS, 2018-2030 (USD MILLION)
  • TABLE 226. TURKEY DEGENERATIVE DISC DISEASE MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 227. TURKEY DEGENERATIVE DISC DISEASE MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
  • TABLE 228. UNITED ARAB EMIRATES DEGENERATIVE DISC DISEASE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 229. UNITED ARAB EMIRATES DEGENERATIVE DISC DISEASE MARKET SIZE, BY DEVICES, 2018-2030 (USD MILLION)
  • TABLE 230. UNITED ARAB EMIRATES DEGENERATIVE DISC DISEASE MARKET SIZE, BY DRUGS, 2018-2030 (USD MILLION)
  • TABLE 231. UNITED ARAB EMIRATES DEGENERATIVE DISC DISEASE MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 232. UNITED ARAB EMIRATES DEGENERATIVE DISC DISEASE MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
  • TABLE 233. UNITED KINGDOM DEGENERATIVE DISC DISEASE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 234. UNITED KINGDOM DEGENERATIVE DISC DISEASE MARKET SIZE, BY DEVICES, 2018-2030 (USD MILLION)
  • TABLE 235. UNITED KINGDOM DEGENERATIVE DISC DISEASE MARKET SIZE, BY DRUGS, 2018-2030 (USD MILLION)
  • TABLE 236. UNITED KINGDOM DEGENERATIVE DISC DISEASE MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 237. UNITED KINGDOM DEGENERATIVE DISC DISEASE MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
  • TABLE 238. DEGENERATIVE DISC DISEASE MARKET SHARE, BY KEY PLAYER, 2023
  • TABLE 239. DEGENERATIVE DISC DISEASE MARKET, FPNV POSITIONING MATRIX, 2023